[REVISION HISTORY]
COVID-19 disease overview
1 recorded revision of this situation.
What changed
2026-08-03 14:55 UTC → 2026-08-07 13:14 UTC ·
added
removed
The first snapshot ongoing narrative provides a comprehensive description concise factual overview of COVID‑19, outlining describing its origin emergence in early 2020, typical symptoms, symptoms (fever, fatigue, cough, dyspnea, loss of smell/taste), severity distribution, distribution (≈81 % mild/moderate, 14 % severe, 5 % critical), heightened risk factors for older adults, and the possibility of long‑COVID, transmission routes, diagnostic methods, approved vaccines, long‑COVID. Transmission occurs primarily via inhaled respiratory particles, close contact and recommended contaminated surfaces, with individuals remaining contagious for up to 20 days. Diagnostic approaches rely on nucleic‑acid detection (RT‑PCR, transcription‑mediated amplification, RT‑LAMP) from nasopharyngeal swabs. Multiple vaccines have been authorized worldwide, and public‑health measures. The second snapshot, dated a few weeks later, repeats measures such as physical distancing, mask‑wearing, ventilation, hand hygiene and quarantine continue to be recommended. Snapshots from August 2026 reiterate the same core information with only minor wording changes information, confirming that the disease’s clinical profile, transmission dynamics and adds control strategies have remained consistent. The latest entries explicitly note virus viability in air and on objects for varying periods and reference Brazil and Argentina to among the list of countries referenced. where vaccination campaigns are ongoing. No new developments or policy changes shifts or scientific developments are reported, indicating that underscoring the overall portrayal of continued reliance on established mitigation and vaccination efforts. Overall, the disease situation remains consistent. Together, the snapshots illustrate an ongoing effort to maintain a standard factual stable, globally‑relevant overview of COVID‑19 for a global audience, COVID‑19, emphasizing the disease’s unchanged disease characteristics and the continued use of vaccination and mitigation strategies. sustained public‑health recommendations.
Versions
Select a version to see what changed compared to the one before it.